Abstract. Lymphocyte migration from the blood into most secondary lymphoid organs is initiated by a highly selective adhesive interaction with the endothelium of specialized blood vessels known as high endothelial venules (HEV). The propensity of lymphocytes to migrate to particular lymphoid organs is known as lymphocyte homing, and the receptors on lymphocytes that dictate interactions with HEV at particular anatomical sites are designated "homing receptors". Based upon antibody blockade experiments and cell-type distribution studies, a prominent candidate for the peripheral lymph node homing receptor in mouse is the =90-kD cell surface glycoprotein (gp90 MEL) recognized by the monoclonal antibody MEL-14. Previous work, including sequencing of a cDNA encoding for this molecule, supports the possibility that gp90 uEL is a calcium-dependent lectin-like receptor. Here, we show that immunoaffinity-purified gp90 MEL interacts in a sugar-inhibitable manner with sites on peripheral lymph node HEV and prevents attachment of lymphocytes. Lymphocyte attachment to HEV in Peyer's patches, a gut-associated lymphoid organ, is not affected by gp90 MEL. The results demonstate that gp90 MEL, as a lectin-like receptor, directly bridges lymphocytes to the endothelium.
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VUPHOCVTES move extensively throughout the body, migrating from the blood into lymphoid organs and back to the blood again via lymphatics. The overall process, known as lymphocyte recirculation, is an essential component of immune surveillance as it brings potentially responsive lymphocytes into contact with antigens sequestered within secondary lymphoid organs (reviewed in Butcher, 1986; Duijvestijn and Hamann, 1989; Ford, 1975; Stoolman, 1989; Woodruff et al., 1987; Yednock and Rosen, 1989) . Entry of blood-borne lymphocytes into all secondary lymphoid organs, except the spleen, is initiated by a highly specific cell-cell recognition event between lymphocytes and the endothelial cells of specialized postcapillary venules found within these organs (Gowans, 1959; Gowans and Knight, 1964) . These venules are characterized by having a cuboidal or high endothelial lining and are referred to as high endothelial venules (HEV).~ The adhesive interactions between lymphocytes and HEV have been studied in vivo with short term recirculation studies (reviewed in Butcher et al., 1980) and in vitro with the highly validated Stamper-Woodruff adherence assay (Stamper and Woodruff, 1976) , in which viable lymphocytes, overlaid onto cryostat-cut sections of lymphoid organs, selectively adhere to sectioned profiles of HEV. Three distinct adhesive specificities have been shown to ex-ist, one governing lymphocyte attachment to HEV in peripheral lymph nodes (PN), another for gut-associated Peyer's patches (PP), and a recently identified specificity for lungassociated lymph nodes (Butcher et al., 1980; Chin et al., 1983; Chin et al., 1984; Geoffroy et al., 1988) . 2 It has been postulated that the endothelial cells of HEV bear cell surface ligands that are distinctive for particular lymphoid organs or anatomically related collections of lymphoid organs (Butcher and Weissman, 1984) . The ligands are the heterophilic adhesion partners for a set of complementary lymphocyte receptors. Depending on a lymphocyte's developmental stage, class, subclass, and history of antigenic stimulation, the particular array of receptors expressed by the cell determines its ability to bind to and hence initiate extravasation across HEV in different anatomical sites (for review, see Butcher, 1986) . "Homing receptor" is the designation applied to this set of lymphocyte adhesion receptors, reflecting their primary role in controlling the distinctive migratory or "homing" propensities of lymphocyte and lymphoma populations. The activity of these specific adhesion molecules appears to be supplemented by accessory molecules such as LFA-1, which act to strengthen the lymphocyte-HEV interaction without contributing to target organ specificity (Hamann et al., 1988; Pals et al., 1988) . The use of this system of highly refined homing specificities is believed to lie in its potential to regulate the exact mix of functional subpopulations which populate each lymphoid organ such that immune responses initiated within are appropriate and maximally efficient for the particular anatomical site (Butcher, 1986 
Materials and Methods

Materials
Purification of Ann'gen
The purification of gp90 MEL was achieved by a modification of a previously described procedure (Lasky et al., 1989) . The starting material was frozen mouse spleens or mesenteric lymph nodes. Tissues were minced with a razor blade and then homogenized with a Potter-Elvehjem tissue grinder in 5 ml of lysis buffer (2% Triton-X 100 in Dulbecco's phosphate buffered saline [PBS] , containing 1 m_M PMSF, 1% aprotinin, and 0.02% NAN3) per gram (wet weight) tissue. Typical preparations used tissues from 200 animals. The lysates were prepared, clarified, and precleared with rat serum-Sepharose 413 as previously described (Lasky et al., 1989) . The flow through from the rat-serum column was applied to a 4-ml column of Sepharose 4B conjugated with MEL-14 mAb (1 mg mAb/ml Sepharose) which had been equilibrated in lysis buffer. The column was washed consecutively with 10 ml of lysis buffer followed by 30 ml of column buffer (10 mM CHAPS in PBS containing 1 mM PMSF, I% aprotinin, and 0.02% NAN3). Antigen was released from the column in 15 ml of a low pH buffer (10 mM CHAPS, 100 mM glycine, 200 mM NaCI, 1% aprotinin, 1 mM PMSE 0.02% NAN3, pH 3) and collected into 1.5 ml of I M Tris-HCl (pH 7.6) to neutralize the pH. After antigen release, the column was washed with 20 mM triethylamine, 200 mM NaCI (pH 11) and reequilibrated with column buffer. The antigen, which was diluted to 50 ml in column buffer, was re.applied to the column, and the elution procedure was repeated. The purified protein was concentrated in two steps by sequential use of Centriprep 30 and Centricon 30 concentrators. Purity was evaluated by SDS-PAGE with visualization by silver staining (Merrill et al., 1981) . Based upon comparisons with alpha 1 acid glucoprotein standards, typical yields were 25-35 tLg glO0 MEL per 200 spleen and 20-30 ~g from mesenteric lymph nodes from 200 animals. No difference could be detected in the biological activity of gp90 MEL isolated from the two sources. The molecular weight distribution of antigen isolated from spleen was slightly broader than that from mesenteric lymph nodes.
Binding Assay
In a series of experiments, it was determined that the presence of 250 #M CHAPS in the assay medium did not interfere with the viability of lymphocytes (as assessed by Trypan blue exclusion) or their ability to bind to HEV in sections of PN and PP. Purified gp90 MeL in column buffer was equilibrated with 500 #M CHAPS in RPMI 1640 (CHAPS/RPMI) by several exchanges in a Centricon 30 concentrator. BSA was added to antigen solutions to a final concentration of I mg/ml. Control buffer solutions were prepared in the same way. One part of antigen solution was mixed with one part of RPMI (2 mg/ml BSA) containing potential inhibitors (phosphorylated sugars, polysaccharides, or MEL-14 mAb), and the mixture was incubated for 1 h at 40C before incubation with the tissue sections (see below). PNs and PPs, dissected from ICR mice, were mounted on a cushion of gum tragacanth and snap-frozen in 2-methylbutane cooled in a liquid nitrogen bath. Cryostat-cut sections (10 tim) were picked up on epoxy-coated well slides (Carlson Scientific, Inc., Peotone, IL). The slides were fixed in 1% paraformaldehyde in 0.1 M sodium cacodylate (pH 7.3) for 20 min at 4"C, and subsequently rinsed in PBS. Appropriate dilutions of purified antigen or control buffer were applied to the wells (75/~1 per well), and the slides were placed on a metal pan supported by an ice pack and rotated on an orbital shaker for 30 rain at 50 rpm. The slides were then washed in a 250 ml bath of PBS (40C) and then subjected to the Stamper-Woodruff in vitro adherence assay (Stamper and Woodruff, 1976) with the modifications described p~viously (Yednock et al., 1987b) . Mesenteric lymph node lymphocytes (107 per ml in a volume of 100/zl per well) were used as test cells. At least four replicate sections were used for the control condition (buffer) and for each experimental condition. Values for lymphocytes bound per unit area HEV were determined by digital morphometry on a Bioquant image analyzer (R & M Biometrics, Nashville, TN). Samples were coded and evaluated blindly. At least 15 segments of HEV were counted for each PN and PP section. In the different experiments, control levels of binding ranged from 24 to 61 lymphocytes per 100 square micrometers HEV for PN and from 30 to 67 lymphocytcs per 100 square micrometers HEV for PP.
Results
Our overall approach was based upon one developed by Springer, Shaw, and their respective colleagues (Dustin et al., 1989; Plunker et al., 1987; Selvaraj et al., 1987) to study a receptor-ligand interaction that underlies a number cells and block intercellular adhesion. In reciprocal experiments, isolated LFA-3 was demonstrated to interact with CD2 on intact T-cells and block adhesion. A key to these studies was that the solubility and biological activity of the purified transmembrane glycoproteins could be maintained in a low detergent concentration, which was compatible with the viability of the test cells. Guided by the strategy of these experiments, we wished to determine whether purified gp90 M~L could bind to HEV in cryostat-eut sections of PN and prevent lymphocyte attachment in the Stamper-Woodruff in vitro adherence assay. With mouse spleen and mesenteric lymph nodes as the sources of antigen, purification was achieved by immunoaflinity chromatography on a MEL-14 mAb column (see Materials and Methods). In a typical preparation, the purified material was resolved by SDS-PAGE as a major diffuse band at 90 kD and variable amounts of a minor (<10%) 180-kD band (Fig. 1) . The larger component appears to be a dimer of the smaller, since upon electroelution and reelectrophoresis it is substantially converted to the 90-kD form (Brian Williams and S. Rosen, unpublished observations). We chose CHAPS as the detergent for the purified antigen, because it is relatively nondenaturing and can be readily removed by membrane filtration. We determined (data not shown) that the maximum concentration of CHAPS compatible with the Stamper-Woodruff assay was 250/~M. When the assay was performed at this concentration or lower, the density of lymphocytes bound per unit area of HEV was equivalent to that in detergent-free buffer.
Cryostat-cut sections of PN were pretreated for 30 rain with gp90 MEL in 250 t~M CHAPS or with this concentration of detergent alone. The sections were washed in detergentfree medium and tested for their ability to support lymphocyte attachment to HEV. As shown in Fig. 2 , lymphocyte binding to PN HEV was almost completely blocked after exposure of the sections to 1 ~g of gp90 uEL ('~100 nM). In contrast, pre-exposure of lymphocytes to the same antigen concentration followed by washing of the cells resulted in no decrement in lymphocyte attachment to HEV. Thus, the isolated antigen exerted its inhibitory effect on the HEV and not the lymphocyte, consistent with the suspected role of gp90 M~-as a lymphocyte-associated adhesive receptor.
Although the antigen preparations were >90 % pure (Fig.  1) , it was essential to demonstrate that the inhibitory activity of the purified antigen was, in fact, due to gp90 M~ and not to a contaminant. To address this issue, PN sections were pretreated with purified gp90 MEL in the presence and absence of MEL-14 mAb. After the preincubation step, the sections were washed extensively so that antibody would not be available to react with the test lymphocytes. As shown in Fig.  3 , the antibody completely prevented the inhibitory activity of the purified antigen. Thus, the active constituent in the immunoisolated material must be the antigen itself.
As reviewed above, gp90 uEL is believed to be involved in organ-specific lymphocyte adhesion to HEV. It was therefore of interest to determine whether isolated gp90 ~EL would interfere with lymphocyte attachment to PP HEV as it did with attachment to PN. When sections of PP were pretreated with up to 2 t~g of purified antigen, there was no inhibition of subsequent lymphocyte attachment (Fig. 4) . With the same antigen preparation tested in parallel, 0.1 #g of antigen produced '~50% inhibition of lymphocyte attachment to PN HEV, and at 0.25 #g and above, inhibition was >80% (Fig. 4) . Thus, gp90 uEL was at least 20-fold more active on the PN HEV sites than the PP HEV sites. Representative micrographs illustrating the differential effects of antigen on lymphocyte attachment activity of the two kinds of HEV are shown in Fig. 5 . The demonstration above that purified gp90 ~L has biological activity allowed us to test directly the predicted lectin function of the molecule. Our previous work had shown that millimolar levels of nmnnose-6-phosphate (M6P) or of the structurally related fructose-l-phosphate (FIP) block lymphocyte attachment to PN HEV by reacting with gp90 MsL or a closely associated molecule on the lymphocyte surface (Yednock et al., 1987a,b) . If these effects were, in fact, through a direct interaction of the sugars with gpg0 MEL, then biological activity of isolated gp90 MsL should be competed by the same sugars. As shown in Fig. 6 , 100 nM of either M6P (A) or F1P (B) largely prevented the blockade of PN HEV sites by gpg0 ~EL. Three control sugars, fructose-6-phosphate (A), galactose-6-phosphate, and glucose-6-phosphate (B), all previously shown to be relatively inactive in blocking lymphocyte attachment to PN HEV, did not antagonize the inhibitory activity of the isolated antigen. Competition experiments were also conducted with the M6P-rich mannan called PPME, a highly specific ligand for the active site of the PN homing receptor (Stoolman et al., 1984; Yednock et al., 1987b) . As expected, this polysaccharide prevented the adhesion-blocking activity of gp90 M~L, whereas two control mannans (mnn 1 and mnn 2) were inactive (Fig. 7) .
Discussion
Previous work has established that gp90 MEL is essential for PN homing, but heretofore, there has been no direct information bearing on whether this receptor could, itself, bind to HEV-ligands. The earlier results, for example, are compatible with the possibility that gp90 M~ interacts with other lymphocyte surface molecules, either integral or peripheral membrane components, to form a homing receptor complex. Thus an element of the complex, other than gpg0 "eL, could form the actual bridge to the endothelium. The demonstration above that isolated glO0 M~ can react with HEV and block the lymphocyte attachment activity of the HEV leads to the unequivocal conclusion that gp90 u" is capable of a direct binding interaction with HEV ligands. Moreover, this interaction is organ specific as established by the selective inactivation of PN sites as compared to PP sites. Thus, the information required for the selective interaction of lympbocytes with the endothelium of PN HEV resides, at least in part, within the ~90 MEL molecule. Determining whether gp90 M~L, by itself, is capable of mediating the lymphocyte-HEV adhesive interaction will require reconstitution experiments with the purified glycoprotein or alternatively, transfection experiments with its eDNA. Although gp90 u~L may be sufficient for the interaction, it seems probable, in light of results from this system (Hamann et al., 1988; Pals et al., 1988) and from related systems (Goverman et al., 1986; Springer et al., 1987) , that general adhesion molecules (e.g., LFA-1) may be necessary to supplement the molecules conferring target organ-specificity (e,g,, gp90MeL).
Our finding that isolated gp90 ~a~L blocks the adhesive iigands of PN HEV is highly reminiscent of the activity of HEBFLN in the rat system (Chin et al., 1983; Chin et al., 1984; Rasmussen et al., 1985) . This factor was originally detected as a soluble factor in lymph fluid. It is apparently derived by a shedding process from integral membrane components of the lymphocyte plasma membrane. In this regard, it is noteworthy that brief incubation of mouse lymphocytes at 37°C results in the shedding of substantial amounts of soluble gpg0 uEL with a slightly decreased (4-5 kD) molecular mass (Yednock, T. A., J. S. Geoffroy, and S. D. Rosen, unpublished) . Both the soluble and membrane forms of HEBFLN are capable of blocking the activity of PN HEV ligands in an organ selective manner (Chin et al., 1984; Rasmussen et al., 1985) . The molecular masses of the membrane form (135, 63, and 40 kD) of HEBFLs (rat), as defined by immunopre- Fruc-l-P Gal~-P GIc-6-P Figure 6 . Effects of phosphorylated monosaccharides on the adhesion-blocking activity of gp90 MEL. Purified gp90 uEL was mixed with control buffer or with sugars (100 nM final concentration) for 60 min before the mixtures were applied (1 #g of glD0 MEL per section) to sections of PN. The sections were pretreated for 30 min, and washed before the binding assay. Data are expressed as a percent of control binding (no gp90 u~L) as above. Error bars denote SEMs for four replicate sections. (.4) Mannose-6-phosphate (Man-6-P) or fructose-6-phosphate ( Fruc-6-P ). ( B ) Fructose-l-phosphate (Fruc-/-P), galactose-6-phosphate (Gal-6-P), or glucose-6-phosphate (GIc-6-P).
cipitation with a monoclonal antibody (Rasmussen et al., 1985) , do not bear any obvious relationship to that of gpg0 M~ from mouse lymphocytes. Nonetheless, the striking functional parallels indicate the need for further exploration of the possibility that HEBFLN and gp90 ~EL might be species homologues. The present studies confirm previous predictions that gp90 mL functions as a lectin. M6P and F1P, two structurally related monosaccharides (Kaplan et al., 1977) that are active in blocking lymphocyte attachment to PN HEV, were shown to inhibit the activity of the isolated receptor, whereas three control phosphorylated monosaccharides were inactive Figure 7. Effects ofpolysaccharides on the adhesion-blocking activity of gpgO u~-. Purified gp90 MEL was incubated with control buffer or 100 #g/ml ofPPME, mrml marman, or mnrd mannan for 60 min before applying mixtures (1 #g of gp90 uEL per section) to sections of peripheral node. Sections were pretreated for 30 min and then rinsed thoroughly before the binding assay. Data are expressed as a percent of control binding (no gp9OUSL). Error bars denote SEMs for four replicate sections.
at the same concentrations. Similarly, PPME (a M6P-rich polysaccharide that potently competes lymphocyte attachment to PN HEV) also selectively blocked the activity of isolated gp90 MEL. Of particular note is that antagonism of the isolated receptor by M6P or FIP was observed at I00 nM, a concentration that is •104 lower than required for inhibition of lymphyocyte attachment to PN HEV. This dramatic potentiation might be explained by considerations of avidity.
In the experiments with isolated receptor, the monosaccharides are competing the interaction of solubilized receptor molecules with sites on the HEV, whereas in the cell-cell adhesion assay, the lectin-like receptors that must be competed are presented in a highly multivalent array on the lymphocyte surface. The demonstration presented herein, that gp90 M~L can interact directly with sites on PN HEV focuses attention on the nature of the HEV-associated ligands for this receptor. In view of the mounting evidence that this receptor functions as a lectin, it is strongly suspected that the recognition determinant of its cognate HEV-ligand will be carbohydrate in nature. Evidence is already available that sialic acid residues are essential for the function of the PN HEV ligands, although it is not yet known whether this sugar contributes directly to the actual recognition determinant or instead has a modulatory role Rosen et al., 1985) . One prominent candidate for the PN HEV ligand is the 92-kD HEV-associated antigen detected by the MECA-79 antibody (Streeter et al., 1988b; Berg et al., 1989) . This antibody selectively stains HEV of PN and blocks lymphocyte attachment. Future work should address whether this antigen or a physically associated molecule expresses a carbohydrate determinant that is recognized by gp90 uEL. The possibility exists that the EGF-like and complement regulatory domains of gp90 MEL might also contribute to the interaction with ligand molecules. The capability to produce recombinant forms of gp90 uEL in substantial quantities should provide tools that expedite the identification and biochemical dissection of the relevant endothelial molecules of PN HEV. Eventually, the analysis will undoubtedly progress to the distinct, but presumably related HEV ligands at other anatomical locations.
